Did you know? You can suggest edits to improve this peptide information.
Overview
What is Prostamax?
Prostamax (Lys-Glu-Asp-Pro/KEDP) is a synthetic tetrapeptide bioregulator from the Khavinson peptide family that demonstrates prostate-specific tissue effects. Preclinical research shows anti-inflammatory and tissue-protective properties in chronic prostatitis models, with emerging interest in epigenetic chromatin regulation and anti-aging applications. Human clinical trial data remains limited.
Key Benefits
Direct systemic delivery, optimal bioavailability for prostate tissue targeting, established preclinical protocols
Mechanism of Action
Subcutaneous injection provides systemic circulation for tissue-specific bioregulation of prostate gland cells
Molecular Information
Weight
487.5 Da
Length
4 amino acids
Type
Tetrapeptide
Amino Acid Sequence:
Lys-Glu-Asp-Pro (KEDP)
* Synthetic Khavinson peptide bioregulator with prostate tissue specificity
Research Indications
Chronic Prostatitis
Preclinical studies show reduced inflammation markers including tissue swelling, vascular hyperemia, and lymphoid infiltration in chronic aseptic prostatitis models
Anti-Sclerotic Effects
Research demonstrates prevention of sclerotic and atrophic processes that characterize chronic inflammatory prostate conditions
Tissue Regeneration
Enhanced proliferative and metabolic activity in prostate epithelial cells and fibroblasts in culture systems
Research Protocols
Disclaimer
These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing
Morning administration recommended. Rotate injection sites to prevent irritation.
Peptide Interactions
How to Reconstitute
Important
Always use bacteriostatic water (BAC). Sterile technique is essential.
Remove lyophilized powder from refrigeration and allow to reach room temperature
Clean vial tops with alcohol swabs and allow to dry completely
Add 2.0mL bacteriostatic water to achieve 10mg/mL concentration
Inject water slowly down the side of the vial to minimize foaming
Gently swirl (do not shake) until powder dissolves completely - solution should be clear
Store reconstituted solution in refrigerator at 2-8°C
Use within 14 days of reconstitution for optimal potency
Quality Indicators
White Lyophilized Powder
Prostamax should appear as white to off-white freeze-dried powder indicating proper manufacture
Clear Reconstituted Solution
When properly mixed, solution should be crystal clear with no particles or cloudiness
Certificate of Analysis
Reputable sources provide third-party testing documentation showing 99%+ purity
Research Grade Product
Prostamax is sold as a research peptide - not approved for human consumption in most jurisdictions
Discolored or Clumped Powder
Yellow, brown, or heavily clumped powder indicates degradation or contamination
Cloudy Solution
Persistent cloudiness or precipitates after mixing indicate degraded or contaminated peptide
What to Expect
- Week 1-2: Subtle improvements may begin; reduced inflammation markers in preclinical models
- Week 2-3: Enhanced tissue function and cellular activity based on animal studies
- Week 3-4: Peak effects observed in preclinical research protocols
- Side effects: Mild injection site reactions possible
- Note: Human clinical data is limited - effects extrapolated from preclinical research
Side Effects & Safety
- Human clinical trial data not yet published - dosing extrapolated from preclinical models
- Possible mild injection site reactions (redness, swelling)
- Rare reports of mild digestive discomfort or headache
- Contraindicated when active prostate malignancy exists - theoretical concern for tumor growth stimulation
- Not recommended during pregnancy or lactation
- Quality sourcing critical - verify purity and avoid contaminated products
References
Benign Prostatic Hyperplasia Model (2014)
Study examining tetrapeptide Lys-Glu-Asp-Pro effects in benign prostatic hyperplasia model, showing favorable effects on prostate weight and histological parameters.
View Study (opens in new tab) →Chronic Aseptic Prostatitis - Rat Model (2013)
Experimental study demonstrating Prostamax reduces inflammation markers (swelling, hyperemia, lymphoid infiltration), prevents sclerotic and atrophic processes, and enhances sexual activity. Efficacy surpassed Serenoa repens and animal prostate extracts.
View Study (opens in new tab) →Deheterochromatinization in Aging (2012)
Georgian Medical News study confirming Prostamax (KEDP) induces deheterochromatinization in chromatin from elderly subjects, potentially reversing age-related gene silencing.
View Study (opens in new tab) →Quick Start Guide
Community Poll
Question 1 of 10
What is your experience with this compound?
Poll Results
Loading results...
Community Insights
Self-reported by PepPedia users. Not clinical evidence. Health changes reflect all users, including those taking multiple compounds.
Was this helpful?
Your feedback helps us improve PepPedia